Lisbet A Christensen
Overview
Explore the profile of Lisbet A Christensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Julsgaard M, Hvas C, Gearry R, Gibson P, Fallingborg J, Sparrow M, et al.
Inflamm Bowel Dis
. 2019 May;
26(1):93-102.
PMID: 31141607
Background: Active inflammatory bowel disease (IBD) adversely affects pregnancy outcomes. Little is known about the risk of relapse after stopping anti-tumor necrosis factor (anti-TNF) treatment during pregnancy. We assessed the...
2.
de Silva P, OToole A, Marc L, Ulysse C, Testa M, Julsgaard M, et al.
Inflamm Bowel Dis
. 2018 Aug;
24(11):2350-2359.
PMID: 30165525
Background: Women with inflammatory bowel disease (IBD) may have decreased sexual function. To understand how common this condition is in our female patients, we developed a new IBD-specific Female Sexual...
3.
Vestergaard T, Brock B, Christensen L, Julsgaard M
J Crohns Colitis
. 2017 Apr;
11(10):1284-1285.
PMID: 28369262
No abstract available.
4.
Julsgaard M, Hvas C, Christensen L, Bell S
Gastroenterology
. 2016 Nov;
151(6):1250-1251.
PMID: 27810368
No abstract available.
5.
Oppfeldt A, Dahlerup J, Christensen L, Hvas C
BMJ Case Rep
. 2016 Sep;
2016.
PMID: 27664230
Faecal microbiota transplantation (FMT) is increasingly being used to treat refractory and recurring Clostridium difficile infection (CDI). Although FMT appears to be safe and highly effective in patients with a...
6.
Hvas C, Dige A, Bendix M, Wernlund P, Christensen L, Dahlerup J, et al.
Eur J Clin Invest
. 2016 Apr;
46(6):555-63.
PMID: 27090817
Background: In ulcerative colitis (UC), dietary supplements may have anti-inflammatory properties and improve disease course. We investigated the effects of casein glycomacropeptide (CGMP), a fraction of bovine whey protein, in...
7.
Julsgaard M, Christensen L, Gibson P, Gearry R, Fallingborg J, Hvas C, et al.
Gastroenterology
. 2016 Apr;
151(1):110-9.
PMID: 27063728
Background & Aims: Little is known about in utero exposure to and postnatal clearance of anti-tumor necrosis factor (anti-TNF) agents in neonates. We investigated the concentrations of adalimumab and infliximab...
8.
Bartels L, Jepsen P, Christensen L, Gerdes L, Vilstrup H, Dahlerup J
J Crohns Colitis
. 2015 Dec;
10(4):443-8.
PMID: 26674958
Background And Aims: Helicobacter pylori infection may protect against some chronic inflammatory diseases. This study examined H. pylori infection and its association with the prevalence of the gastrointestinal diseases Crohn's...
9.
Schosler L, Christensen L, Hvas C
Scand J Gastroenterol
. 2015 Oct;
51(3):288-94.
PMID: 26452305
Objective: The presentation of celiac disease (CD) has changed over the past decades. We aimed to describe the incidence of CD and its complications at diagnosis in a historical cohort...
10.
Steenholdt C, Brynskov J, Thomsen O, Munck L, Christensen L, Pedersen G, et al.
J Crohns Colitis
. 2015 Aug;
9(11):1032-42.
PMID: 26245216
Background: This study assessed the effects of infliximab (IFX) treatment failure on patient-reported outcomes and explored the influence of using personalized treatment in this situation. Methods: Sixty-nine Crohn's disease patients...